NF-kappaB decoy

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameNF-kappaB decoy
Drug Alias NameNF-kB decoy oligoNF-kB DecoyNF-kappa-B decoy oligoAvrina
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAnesiva Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnesiva Inc
Active IndicationsN/A
Inactive IndicationsDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A